检索结果 - Sándor Czibor
- Showing 1 - 3 results of 3
-
1
Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma 由 Jakoba J. Eertink, Gerben J. C. Zwezerijnen, Martijn W. Heymans, Simone Pieplenbosch, Sanne E. Wiegers, Ulrich Dührsen, Andreas Hüttmann, Lars Kurch, Christine Hanoun, Pieternella J. Lugtenburg, Sally F. Barrington, N. George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sándor Czibor, Tamás Györke, Martine E.D. Chamuleau, Otto S. Hoekstra, Henrica C. W. de Vet, Ronald Boellaard, Josée M. Zijlstra
出版 2023Artigo -
2
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients 由 Jakoba J. Eertink, C. N. Burggraaff, Martijn W. Heymans, Ulrich Dührsen, Andreas Hüttmann, Christine Hanoun, Stefan Müller, Pieternella J. Lugtenburg, Sally F. Barrington, N. George Mikhaeel, Robert Carr, Sándor Czibor, Tamás Györke, Luca Ceriani, Emanuele Zucca, Martin Hutchings, Lale Kostakoğlu, Annika Loft, Stefano Fanti, Sanne E. Wiegers, Simone Pieplenbosch, Ronald Boellaard, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C. W. de Vet
出版 2021Artigo -
3
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients 由 Maria C. Ferrández, Sandeep S.V. Golla, Jakoba J. Eertink, Bart M. de Vries, Pieternella J. Lugtenburg, Sanne E. Wiegers, Gerben J. C. Zwezerijnen, Simone Pieplenbosch, Lars Kurch, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Henrica C. W. de Vet, Otto S. Hoekstra, Coreline N. Burggraaff, Annelies Bes, Martijn W. Heymans, Yvonne W. S. Jauw, Martine E.D. Chamuleau, Sally F. Barrington, G. Mikhaeel, Emanuele Zucca, Luca Ceriani, Robert Carr, Tamás Györke, Sándor Czibor, Stefano Fanti, Lale Kostakoğlu, Annika Loft, Martin Hutchings, Sze Ting Lee, Josée M. Zijlstra, Ronald Boellaard
出版 2023Artigo
相关主题
Diffuse large B-cell lymphoma
Internal medicine
International Prognostic Index
Lymphoma
Medicine
Nuclear medicine
Oncology
Positron emission tomography
Radiology
Archaeology
Chemotherapy
Confidence interval
Cyclophosphamide
Disease
Framingham Risk Score
Hazard ratio
History
Interim
Overall survival
Predictive value
Prednisone
Progression-free survival
Proportional hazards model
Radiomics
Rituximab
Standardized uptake value
Vincristine